FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,419,965 | +28.5% | 1,445,938 | -4.5% | 0.00% | – |
| Q2 2023 | $4,997,603 | -58.1% | 1,514,425 | -63.8% | 0.00% | – |
| Q1 2023 | $11,923,654 | -49.9% | 4,183,738 | +28.0% | 0.00% | -100.0% |
| Q4 2022 | $23,798,256 | +6.1% | 3,268,991 | +17.9% | 0.00% | 0.0% |
| Q3 2022 | $22,428,000 | +72.5% | 2,772,344 | +4.4% | 0.00% | – |
| Q2 2022 | $13,005,000 | -75.3% | 2,654,378 | +19.1% | 0.00% | -100.0% |
| Q1 2022 | $52,707,000 | +34.9% | 2,228,610 | +0.9% | 0.00% | 0.0% |
| Q4 2021 | $39,063,000 | -31.8% | 2,208,078 | +8.7% | 0.00% | -50.0% |
| Q3 2021 | $57,290,000 | +321.3% | 2,030,873 | +56.5% | 0.00% | – |
| Q2 2021 | $13,598,000 | +2.3% | 1,297,445 | +15.0% | 0.00% | – |
| Q1 2021 | $13,294,000 | +8.8% | 1,128,579 | +8.2% | 0.00% | – |
| Q4 2020 | $12,217,000 | +133.7% | 1,043,284 | +58.3% | 0.00% | – |
| Q3 2020 | $5,227,000 | -57.4% | 659,197 | -1.7% | 0.00% | – |
| Q2 2020 | $12,261,000 | +65.4% | 670,352 | +7.9% | 0.00% | – |
| Q1 2020 | $7,415,000 | +111.8% | 621,065 | +195.2% | 0.00% | – |
| Q4 2019 | $3,501,000 | +457.5% | 210,376 | +122.4% | 0.00% | – |
| Q3 2019 | $628,000 | – | 94,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |